|
Filed pursuant to Rule 424(b)(3) Registration Nos. 333-66764 |
Prospectus Supplement
(To Prospectus Dated October 9, 2001)
Imagyn Medical Technologies, Inc., a selling shareholder named in the accompanying prospectus has sold, through Jefferies & Company, Inc., as its agent, 150,000 shares of our common stock pursuant to ordinary brokers' transactions on the Nasdaq Stock Market.
| Gross proceeds | $ | 2,534,700 | ||
| Commission | $ | 98,700 | ||
| Net proceeds to the selling shareholder | $ | 2,436,000 | ||
| On October 19, 2001 the last reported sales price of the Common Stock on the Nasdaq Stock Market was | $ | 18.17 |
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
This Prospectus Supplement is dated October 19, 2001